ArticleJournal of B.U.ON. : official journal of the Balkan Union of Oncology

Discordance rates in hormone receptor status between primary and metastatic sites might incluence clinical outcome in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.

Kadri AltundagPubMed ↗

No numbers read from the abstract.